Anti-PI 3 Kinase p85 alpha antibody [EPR5513]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(32 Publications)
Rabbit Recombinant Monoclonal PI 3 Kinase p85 alpha antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 32 publications.
View Alternative Names
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (AB133595)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : PI 3 Kinase p85 alpha knockout HAP1 cell lysate (20 μg)
Lane 3 : Jurkat cell lysate (20 μg)
Lane 4 : THP1 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133595 observed at 90 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab133595 was shown to specifically react with PI 3 Kinase p85 alpha when PI 3 Kinase p85 alpha knockout samples were used. Wild-type and PI 3 Kinase p85 alpha knockout samples were subjected to SDS-PAGE. ab133595 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (ab133595)
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (AB133595)
Lanes 1- 2 : Merged signal (red and green). Green - ab133595 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab133595 was shown to react with PI 3 Kinase p85 alpha in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265116 (knockout cell lysate ab257029) was used. Wild-type HeLa and PIK3R1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab133595 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (ab133595) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
PIK3R1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human PIK3R1 (PI 3 Kinase p85 alpha) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-pik3r1-pi-3-kinase-p85-alpha-knockout-hela-cell-line-ab265116'>ab265116</a>)
Predicted band size: 83 kDa
Observed band size: 90 kDa
false
- WB
Unknown
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (AB133595)
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (ab133595) at 1/1000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
Raji cell lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Lane 4:
MCF7 cell lysate at 10 µg
Lane 5:
C6 cell lysate at 10 µg
Lane 6:
Raw 264.7 cell lysate at 10 µg
Lane 7:
PC12 cell lysate at 10 µg
Lane 8:
NIH3T3 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti Rabbit at 1/2000 dilution
Predicted band size: 83 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-PI 3 Kinase p85 alpha antibody [EPR5513] (AB133595)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-PI 3 Kinase p85 alpha antibody [EPR5513] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P85 alpha modulates intracellular signaling by interacting with other proteins in a complex formation with catalytic subunit p110. This interaction enables the initiation of downstream signaling cascades controlling cell growth proliferation and survival. PI 3 kinase activity mediated by p85 alpha is integral to cellular homeostasis and metabolism helping to execute cellular responses to a variety of growth factors and hormones.
Pathways
PI 3 Kinase p85 alpha integrates into two principal signaling networks: the PI3K-Akt and mTOR pathways. These pathways are instrumental for regulating anabolic processes and cell survival. The p85 form of PI3K interacts with additional proteins such as Akt and mTOR coordinating cellular energy balance promoting protein synthesis and inhibiting apoptosis. Through these interactions the protein ensures that cells respond accurately to nutritional and stress signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (32)
Recent publications for all applications. Explore the full list and refine your search
Journal of biomedical science 32:31 PubMed40016734
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical laboratory analysis 39:e25155 PubMed39829207
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1423903 PubMed39101141
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0305903 PubMed38913698
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e31452 PubMed38831826
2024
Applications
Unspecified application
Species
Unspecified reactive species
Phytotherapy research : PTR 38:3509-3524 PubMed38695125
2024
Applications
Unspecified application
Species
Unspecified reactive species
Applied biochemistry and biotechnology : PubMed38581629
2024
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 61:581-589 PubMed36994813
2023
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 290:1134-1150 PubMed36180981
2022
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 38:28-38 PubMed36114797
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com